Employees: 01 (2023.0)Legal category: 5485Size: PMECreation date: 2023-01-26 (3 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VITRY-SUR-SEINE (94400), Val-de-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE SOUIR : revenue, balance sheet and financial ratios
PHARMACIE SOUIR is a French company
founded 3 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VITRY-SUR-SEINE (94400),
this company of category PME
has financial data available below.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE SOUIR (SIREN 922932009)
Indicator
2025
2024
Revenue
N/C
N/C
Net income
0 €
0 €
EBITDA
N/C
N/C
Net margin
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE SOUIR records a net loss of 0 €. This deficit will reduce equity on the balance sheet.
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 162%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 30%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
161.787%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
29.853%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2024
2025
Debt ratio
101.754
161.787
Financial autonomy
31.952
29.853
Repayment capacity
None
None
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
161.792025
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average+14 pts over 2 years
In 2025, the debt ratio of PHARMACIE SOUIR (161.79) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
29.85%2025
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average
In 2025, the financial autonomy of PHARMACIE SOUIR (29.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 101.53. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
101.528
Liquidity indicators evolution PHARMACIE SOUIR
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2024
2025
Liquidity ratio
141.882
101.528
Interest coverage
None
None
Sector positioning
Liquidity ratio
101.532025
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch-11 pts over 2 years
In 2025, the liquidity ratio of PHARMACIE SOUIR (101.53) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 489 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 1101 days. Excellent situation: suppliers finance 612 days of the operating cycle (retail model).
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
489 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
1101 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE SOUIR
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2024
2025
Operating WCR
0 €
0 €
Inventory turnover (days)
0
0
Customer payment term (days)
334
489
Supplier payment term (days)
1405
1101
Positioning of PHARMACIE SOUIR in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE SOUIR with other companies in the same sector:
The revenue of PHARMACIE SOUIR is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE SOUIR profitable?
Profitability information is not publicly available.
Where is the headquarters of PHARMACIE SOUIR ?
The headquarters of PHARMACIE SOUIR is located in VITRY-SUR-SEINE (94400), in the department Val-de-Marne.
Where to find the tax return of PHARMACIE SOUIR ?
The tax return of PHARMACIE SOUIR is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE SOUIR operate?
PHARMACIE SOUIR operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart